Clene
Clene Nanomedicine is a Utah-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $438k
Employees: 51-200
Rankings
Industries / Tags:
Detailed Clene Information
Geographic Data
Address: 6550 South Millrock Drive
City: Salt Lake City
State: UT
Zip: 84121
Country: US
Financial Info
Stage:
grant
Raised Last:
$1M
Raised Total:$79M
Social
Metrics
3,086,088Website Global Rank
5,471Website Monthly Traffic
Twitter Followers
Description
Clene Nanomedicine is a Utah-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases.
Contact Phone:
+18016769695
Contact Email:
Clene went public on 12/30/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/30/2020
IPO Valuation:
$780M
Ticker Symbol:
CLNN
IPO Price:
$11.88/share
Amount Raised:
$46M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Grant | 1 | $1M |
Maryland Department of Housing and Community Development Maryland Department of Housing and Community Development |
11/2016 | Series B | $17M | 9/2019 | Grant | 1 | $940k |
FightMND FightMND FightMND FightMND |
4/2015 | Series A | $31.6M | 10/2022 | Post-IPO Equity | $10.8M | 2/2020 | Debt Financing | $6.1M | 5/2021 | Private Placement | $9.3M | 12/2020 | IPO SPAC | - | 11/2022 | Post-IPO Debt | $5M | 11/2022 | Post-IPO Equity | $10.8M | 5/2022 | Post-IPO Debt | $3M | 10/2022 | Post-IPO Debt | 1 | $5M |
Maryland Department of Housing and Community Development Maryland Department of Housing and Community Development |
10/2019 | Grant | $0 |
National Multiple Sclerosis Society (NMSS) National Multiple Sclerosis Society (NMSS) |
12/2020 | Post-IPO Equity | 1 | $22.4M |
SymBiosis LLC SymBiosis LLC |
8/2020 | Series D | 1 | $42.5M |
SymBiosis LLC SymBiosis LLC SymBiosis LLC SymBiosis LLC |
12/2020 | IPO SPAC | - | 10/2019 | Grant | 1 | $339k |
National Multiple Sclerosis Society (NMSS) National Multiple Sclerosis Society (NMSS) |
9/2019 | Grant | 1 | $940k |
FightMND FightMND FightMND FightMND |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
